NANCY NIEVES: Open Payments
NPI 1104397512 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 55 payments from 17 companies in 2025. Trend: 2023 $1,894 · 2024 $750 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $259 |
| Novo Nordisk Inc | 11 | $208 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Amgen Inc. | 5 | $79 |
| PFIZER INC. | 3 | $71 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $38 |
Products named: Veozah, Rybelsus, AIRSUPRA, Wegovy, Cologuard Collection Kit, FARXIGA, Ozempic, OTEZLA.
Industry payments across FL — which companies pay providers there.
